Search

Search Constraints

You searched for: Author/Creator Mpoza, Edward

Search Results

1. 869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial. (15th December 2022)

2. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial. Issue 8 (August 2019)

3. Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort. (17th June 2022)

4. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials. (8th January 2020)

5. Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis. (28th November 2020)

6. Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure. (3rd November 2019)

7. Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation. (24th May 2018)

8. HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts. (16th October 2018)

9. Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda. (21st July 2022)